Federal Law
FDA approves Epidiolex (purified CBD), the first FDA-approved prescription medication derived directly from the cannabis plant
On June 25, 2018, the U.S. Food and Drug Administration approved Epidiolex—an oral cannabidiol (CBD) solution for rare childhood epilepsy syndromes—forcing the DEA to reschedule a plant-derived cannabinoid for the first time.